Found: 111
Select item for more details and to access through your institution.
Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 12, p. 3665, doi. 10.1007/s00432-021-03602-w
- By:
- Publication type:
- Article
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 2, p. 403, doi. 10.1007/s00432-017-2556-6
- By:
- Publication type:
- Article
Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 10, p. 1726, doi. 10.3390/jpm12101726
- By:
- Publication type:
- Article
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/8024124
- By:
- Publication type:
- Article
Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5500, doi. 10.3390/ijms21155500
- By:
- Publication type:
- Article
Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 12, p. 4494, doi. 10.3390/ijms21124494
- By:
- Publication type:
- Article
BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 21, p. 5369, doi. 10.3390/ijms20215369
- By:
- Publication type:
- Article
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 6, p. 1503, doi. 10.3390/ijms20061503
- By:
- Publication type:
- Article
Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 6, p. 1240, doi. 10.3390/ijms18061240
- By:
- Publication type:
- Article
Systematic vs. on-demand early palliative care in gastric cancer patients: a randomized clinical trial assessing patient and healthcare service outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
External Validation of Surrogate Indices of Fatty Liver in the General Population: The Bagnacavallo Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 3, p. 520, doi. 10.3390/jcm10030520
- By:
- Publication type:
- Article
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1177, doi. 10.3390/jcm9041177
- By:
- Publication type:
- Article
NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 5, p. 720, doi. 10.3390/jcm8050720
- By:
- Publication type:
- Article
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/7196280
- By:
- Publication type:
- Article
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231171574
- By:
- Publication type:
- Article
Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension.
- Published in:
- La Radiologia Medica, 2017, v. 122, n. 4, p. 257, doi. 10.1007/s11547-016-0714-6
- By:
- Publication type:
- Article
The beneficial impact of metabolic dysfunction‐associated fatty liver disease on lenvatinib treatment in patients with non‐viral hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2023, v. 53, n. 2, p. 104, doi. 10.1111/hepr.13843
- By:
- Publication type:
- Article
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
- Published in:
- Hepatology Research, 2021, v. 51, n. 7, p. 796, doi. 10.1111/hepr.13669
- By:
- Publication type:
- Article
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study.
- Published in:
- Scientific Reports, 2017, p. 42499, doi. 10.1038/srep42499
- By:
- Publication type:
- Article
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC).
- Published in:
- Scientific Reports, 2016, p. 37621, doi. 10.1038/srep37621
- By:
- Publication type:
- Article
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy.
- Published in:
- Scientific Reports, 2016, p. 24136, doi. 10.1038/srep24136
- By:
- Publication type:
- Article
Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib.
- Published in:
- Gastroenterology Insights, 2024, v. 15, n. 3, p. 519, doi. 10.3390/gastroent15030038
- By:
- Publication type:
- Article
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2018, p. 1, doi. 10.1155/2018/7512159
- By:
- Publication type:
- Article
Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920958363
- By:
- Publication type:
- Article
<i>KRAS</i>, <i>BRAF</i> and <i>PIK3CA</i> Status in Squamous Cell Anal Carcinoma (SCAC).
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092071
- By:
- Publication type:
- Article
EGFR, HER-2 and KRAS in Canine Gastric Epithelial Tumors: A Potential Human Model?
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085388
- By:
- Publication type:
- Article
Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study.
- Published in:
- World Journal of Surgical Oncology, 2019, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12957-019-1602-z
- By:
- Publication type:
- Article
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12225-6
- By:
- Publication type:
- Article
Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 13, p. 2828, doi. 10.3390/jcm10132828
- By:
- Publication type:
- Article
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-69548-4
- By:
- Publication type:
- Article
Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 6, p. 780, doi. 10.3390/biom11060780
- By:
- Publication type:
- Article
The Relevance of Nationality and Industry for Stakeholder Salience: An Investigation Through Integrated Reports.
- Published in:
- Journal of Business Ethics, 2018, v. 150, n. 2, p. 541, doi. 10.1007/s10551-016-3194-7
- By:
- Publication type:
- Article
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy?
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4363, doi. 10.3390/cancers15174363
- By:
- Publication type:
- Article
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1647, doi. 10.3390/cancers13071647
- By:
- Publication type:
- Article
Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1617, doi. 10.3390/cancers13071617
- By:
- Publication type:
- Article
Evolution of Surgical Treatment of Colorectal Liver Metastases in the Real World: Single Center Experience in 1212 Cases.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1178, doi. 10.3390/cancers13051178
- By:
- Publication type:
- Article
The Prognostic Value of the New Combined Hemo-Eosinophil Inflammation Index (HEI Index): A Multicenter Analysis of Anal Cancer Patients Treated with Concurrent Chemo-Radiation.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 671, doi. 10.3390/cancers13040671
- By:
- Publication type:
- Article
Recent Research on Gastrointestinal Carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Heterogeneity of Response and Immune System Activity during Treatment with Nivolumab in Hepatocellular Carcinoma: Results from a Single-Institution Retrospective Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 213, doi. 10.3390/cancers13020213
- By:
- Publication type:
- Article
BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3346, doi. 10.3390/cancers12113346
- By:
- Publication type:
- Article
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma: Preliminary Toxicity and Activity Data in Dogs.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1272, doi. 10.3390/cancers12051272
- By:
- Publication type:
- Article
mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1201, doi. 10.3390/cancers12051201
- By:
- Publication type:
- Article